D-0736-2020 Class II Terminated

Recalled by Assurance Infusion — Houston, TX

FDA drug recall D-0736-2020 was initiated by Assurance Infusion on Dec 20, 2019 and is designated Class II. Reason for recall: Lack of sterility assurance. The recall status is terminated (terminated Oct 27, 2021). Affected quantity: 2 vials.

Recall Details

Product Type
Drugs
Report Date
Jan 22, 2020
Initiation Date
Dec 20, 2019
Termination Date
Oct 27, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2 vials

Product Description

HCG 3000U/1ML INJ in 4 mL vial Assurance Infusion (713)533-8800

Reason for Recall

Lack of sterility assurance.

Distribution Pattern

Nationwide within the United States

Code Information

Lots: 11272019@31 Exp. 12/31/2019; 12022019@19 Exp. 01/05/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0736-2020
openFDA file date
Nov 3, 2026
Loaded by RegDataLab
Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0736-2020. Report a data issue: hello@regdatalab.com.